Boston Scientific Corporation (NYSE:BSX) Q1 2026 Earnings Call Transcript
Operator: Good morning, and welcome to the Boston Scientific First Quarter 2026 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sivik Global Healthcare Krishen Sud | 62,000 | $3,891 | -12% | 2.95% |
| 2. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% | |
| 3. | Bourgeon Capital John Zaro | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.29 | 50 | $4,514.60 | 148,168 | 2024-12-03 | Filing | |
| $41.98 | 25,000 | $1,049,450.00 | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | $357.50 | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | $834.00 | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | $740.08 | 32,294 | 2017-04-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $93.49 | 159,701 | $14,930,526.34 | 1,411,735 | 2026-02-02 | Filing | |
| $94.06 | 1,200 | $112,868.04 | 1,571,436 | 2026-02-02 | Filing | |
| $101.55 | 17,313 | $1,758,188.82 | 23,600 | 2025-12-01 | Filing | |
| $98.28 | 12,891 | $1,266,977.75 | 24,134 | 2025-11-06 | Filing | |
| $99.14 | 29,472 | $2,921,895.34 | 178,342 | 2025-11-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,057,936 | $631,135,484 | 0.96% | |
| 2. | 7,308,540 | $458,610,867 | 1.06% | |
| 3. | 5,120,057 | $321,300,991 | 0.34% | |
| 4. | 1,629,485 | $102,250,186 | 0.73% | |
| 5. | 921,164 | $57,803,041 | 0.41% |
News See All
Truist Cuts PT on Boston Scientific Corporation (BSX) to $90 From $92
Boston Scientific Corporation (NYSE:BSX) is one of the most oversold healthcare stocks to invest in. Truist cut the price target on Boston Scientific Corporation (NYSE:BSX) to $90 from $92 on April 15...
8 Most Oversold Healthcare Stocks to Invest In
Calling it a textbook classic move, he stated that we had a geopolitical shock and markets sold off hard before snapping right back up, making it the classic V shape.
10 Best Medical AI Stocks to Buy Now
Artificial intelligence has driven significant gains in the equity market over the past two years.
Boston Scientific Corporation (BSX) Price Target Lowered at Mizuho Ahead of Q1 Medical Device Earnings
TheFly reported on April 13 that Mizuho reduced its price target on BSX to $90 from $115 while maintaining an Outperform rating.
10 Best Healthcare Stocks to Buy and Hold for 3 Years
The first quarter of this year has seen a great deal of volatility in the equity markets. The S&P 500 fell into correction territory before rising again after first soaring to all-time highs.
7 Low-Risk High-Reward Stocks to Buy Now
Last week, volatility-linked and systematic strategies sold $24 billion worth of stocks, Reuters reported on April 8, 2026.
7 Oversold Stocks to Buy with Double-Digit ROE Growth
In this article, we will look at oversold names that offer double-digit ROE growth for investors across sectors.
10 Best Growth Stocks to Buy for the Next Decade
On April 7, Joseph Amato of Neuberger Berman joined CNBC's 'Closing Bell Overtime' to discuss the current market amid volatility and geopolitical concerns, and whether the uncertainty represents a buy...
8 Most Oversold Strong Buy-Rated Stocks to Invest In
Oversold stocks are getting a fresh look in 2026, but not simply because they are down.
Hedge Fund Resource Center